Article

seattletimes.comseattletimes.com on 2018-04-09 12:18

Swiss giant Novartis to buy US-based AveXis in $8.7B deal

GENEVA (AP) — Swiss pharmaceuticals giant Novartis says it has agreed to buy the U.S.-based gene therapy company AveXis Inc. for $8.7 billion, part of ...

Related news